Vitaprost P / o enteric tablets, 20 mg, # 20
Category
BPH
,
Impotence in men
Scope of the medicinal product
Genitourinary system
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
twenty
Tablets from blue to light blue, round, biconvex, inclusions are allowed.
Pharmaco-therapeutic group
N4 Chronic abacterial prostatitis.
Prevention of exacerbations of chronic abacterial prostatitis.
Benign prostatic hyperplasia.
Conditions before and after surgery on the prostate gland.
Application during pregnancy and during breastfeeding
Dosage form
Enteric-coated tablets, 20 mg.
On 10 tablets in a blister strip of a film of polyvinyl chloride or polyvinyl chloride / polyvinylidene chloride and printed aluminum foil varnished.
1, 2 or 3 blisters together with instructions for medical use of the medicinal product in a cardboard box
Shelf life
3 years.
Do not use the drug after the expiration date.
Category
Urology
Name ENG
VITAPROST
Clinical and pharmacological group
An animal drug used for diseases of the prostate gland
ATX code
Other drugs for the treatment of urological diseases
Dosage
20mg
Structure
One tablet contains: active substance: prostate extract - 100 mg (in terms of water-soluble peptides - 20 mg) excipients: sucrose - 28.500 mg, lactose monohydrate - 7.125 mg, calcium stearate monohydrate - 2.500 mg, crospovidone - 9.275 mg, cellulose microcrystalline - up to 102,600 mg shell composition: acrylic (methacrylic acid and ethyl acrylate copolymer [1: 1], titanium dioxide, talc, triethyl citrate, colloidal silicon dioxide, sodium bicarbonate, sodium lauryl sulfate, indigocarmine) - 25 mg.
Indications
Chronic abacterial prostatitis.
Prevention of exacerbations of chronic abacterial prostatitis.
Benign prostatic hyperplasia.
Conditions before and after surgery on the prostate gland.
INN / Active ingredient
Prostate extract
Contraindications
Hypersensitivity to drug components.
Lactase deficiency, sucrase / isomaltase deficiency, lactose intolerance, fructose intolerance, glucose-galactose malabsorption (the drug contains lactose and sucrose).
Storage conditions and periods
At a temperature not higher than 25 ° C.
Keep out of the reach of children.
Specifications
Category
BPH
,
Impotence in men
Scope of the medicinal product
Genitourinary system
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
twenty
Scope of application
Urology
Vacation conditions
Without recipe
Brand name
Vitaprost
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Chronic prostatitis treatment
Anatomical and therapeutic characteristics
G04BX Drugs for the treatment of urological diseases other
Dosage form
Enteric-coated tablets
Packaging
Box
The target audience
Adult
Expiration date in days
1095
Package weight, g
3
Mode of application
:
Inside, 1 tablet 2 times a day.
The duration of the course of treatment with Vitaprost® for benign prostatic hyperplasia is at least 30 days, for chronic prostatitis - at least 10 days.
For the prevention of exacerbations of chronic prostatitis, 1 tablet is used 2 times a day for at least 30 days - 1-2 times a year.
Dosage (volume) of the substance in the preparation
:
1 tablet: prostate extract 100 mg (in terms of water-soluble peptides 20 mg)